Wells Fargo & Company »

Mersana Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $72k 31k 2.32
2023-09-30 $29k 23k 1.28
2023-06-30 $339k 103k 3.29
2022-09-30 $7.3k 1.6k 4.65
2022-06-30 $5.0k 1.1k 4.39
2022-03-31 $71k 18k 4.00
2021-12-31 $259k 42k 6.21
2021-09-30 $0 5.4k 0.00
2021-06-30 $1.3k 52 24.39
2021-03-31 $345k 21k 16.15
2020-12-31 $3.3M 123k 26.61
2020-09-30 $2.4M 129k 18.61
2020-06-30 $3.5M 150k 23.41
2020-03-31 $445k 76k 5.82
2019-12-31 $236k 41k 5.70
2019-09-30 $78k 50k 1.57
2019-06-30 $19k 4.8k 4.03
2019-03-31 $30k 5.7k 5.24
2018-12-31 $23k 5.7k 4.00
2018-09-30 $166k 17k 9.97
2018-06-30 $296k 17k 17.87
2018-03-31 $88k 5.6k 15.72
2017-12-31 $76k 4.7k 16.33